Abstract:Background: The number of diabetic patients has recently been increasing worldwide. Diabetes is a multifactorial disorder based on environmental factors and genetic background. In many cases, diabetes is asymptomatic for a long period and the patient is not aware of the disease. Therefore, the potential biomarker(s), leading to the early detection and/or prevention of diabetes mellitus, are strongly required. However, the diagnosis of the prediabetic state in humans is a very difficult issue, because the lifestyle is variable its each person. Although the development of a diagnosis method in humans is the goal of our research, the extraction and structural identification of biomarker candidates in several biological specimens (i.e., plasma, hair, liver and kidney) of ddY strain mice, which undergo naturally occurring diabetes along with aging, were carried out based upon a metabolite profiling study.Methods: The low-molecular-mass compounds including metabolites in the biological specimens of diabetic mice (ddY-H) and normal mice (ddY-L) were globally separated by ultra-performance liquid chromatography (UPLC) using different reversed-phase columns (i.e.. T3-C18 and HS-F5) and detected by electrospray ionization time-of-flight mass spectrometry (ESI-TOF-MS). The biomarker candidates related to diabetes mellitus were extracted from a multivariate statistical analysis, such as an orthogonal partial least-squares-discriminant analysis (OPLS-DA). followed by a database search, such as ChemSpider. KEGG and HMDB.Results: Many metabolites and unknown compounds in each biological specimen were detected as the biomarker candidates related to diabetic mellitus. Among them, the elucidation of the chemical structures of several possible metabolites. including more than two biological specimens, was carried out along with the comparison of the tandem MS/MS analyses using authentic compounds. One metabolite was clearly identified as N-acetyl-L-leucine based upon the MS/MS spectra and the retention time on the chromatograms.Conclusions: N-acetyl-L-leucine is an endogenous compound included in all biological specimens (plasma, hair, liver and kidney). Therefore, this metabolite appears to be a potential biomarker candidate related to diabetes. Although the structures of other biomarker candidates have still not yet determined, the present approach based upon a metabolite profiling study using UPLC-ESI-TOF-MS could be helpful for understanding the abnormal state of various diseases. (C) 2010 Elsevier B.V. All rights reserved.

Establishment and Optimization of Peptide Biomarker Screening Model in Diabetes in Vitro by HPLC/ESI-TOF Mass Spectrometry

A New Strategy For Early Diagnosis Of Type 2 Diabetes By Standard-Free, Label-Free Lc-Ms/Ms Quantification Of Glycated Peptides

Integrated Strategy for Discovery and Validation of Glycated Candidate Biomarkers for Hemodialysis Patients with Cardiovascular Complications.

Identification of Early Glycated Peptides of Albumin by a Method of Isotopic Labeling Combined with Neutral Loss Scan

Application of a Pseudotargeted MS Method for the Quantification of Glycated Hemoglobin for the Improved Diagnosis of Diabetes Mellitus

Peptide Selection for Accurate Targeted Protein Quantification Via a Dimethylation High-Resolution Mass Spectrum Strategy with a Peptide Release Kinetic Model

RSM optimization of HSA/IL1Ra in Pichia pastoris overexpression strain and study of its in vivo activity in reducing hyperglycemia of GK rats.

Proteomics Study on Cross-Linking Reaction of Formaldehyde and Hsa

Analysis of Peptides in Plasma by High Performance Liquid Chromatography Coupled with Electrospray Ionization Mass Spectrometry

Value of Serum Advanced Glycation End Products-Peptide in the Screening of Diabetes Mellitus in a Community-Based Population of High-Risk Diabetics

Biomarker Discovery in Biological Specimens (plasma, Hair, Liver and Kidney) of Diabetic Mice Based Upon Metabolite Profiling Using Ultra-Performance Liquid Chromatography with Electrospray Ionization Time-Of-Flight Mass Spectrometry

IDDF2019-ABS-0075 Serum Metabonomic Analysis and Establishment of Diagnostic Model of Pancreatic Cancer Associated Diabetes

The Determination of AGE-peptides by Flow Injection Assay, a Practical Marker of Diabetic Nephropathy.

A study on modification of Human Albumin by proteomic technique

Discovery of age-related early-stage glycated proteins based on deep quantitative serum glycated proteome analysis

Practical Analytical Approach for the Identification of Biomarker Candidates in Prediabetic State Based Upon Metabonomic Study by Ultraperformance Liquid Chromatography Coupled to Electrospray Ionization Time-of-flight Mass Spectrometry.

Identification Of Age-Precursors Andage Formation In Glycation-Induced Bsa Peptides

Peptide Markers for Apolipoprotein A -I of Plasma Modified by Glucose

Simplified quantification of insulin, its synthetic analogs and C-peptide in human plasma by means of LC-HRMS

Screening for Potential Serum-Based Proteomic Biomarkers for Human Type 2 Diabetes Mellitus Using Maldi-Tof Ms

The Tryptic Peptides of Hemoglobin for Diagnosis of Type 2 Diabetes Mellitus Using Label-Free and Standard-Free LC-ESI-DMRM